Oregon May Soon Decriminalize Low-Level Possession Of All Drugs, Massively Reducing Arrests
Morgan Stanley Is Getting Bullish About Biotech; Here Are 2 Stocks to Buy
Gilead Says FDA Could Broaden Remdesivir Use Despite Data; Analyst Slashes PT
Gilead remdesivir study finds only marginal benefit for moderate Covid-19 patients
Harvard’s Wyss Institute launches Torus Biosystems
Oppenheimer Says These 2 Stocks Could Surge Over 100% From Current Levels
I'm a lung doctor testing the blood from COVID-19 survivors as a treatment for the sick – a century old idea that could be a fast...
Coronavirus pharma news round-up 21/08/20
Pilot study backs Kaia Health app for back pain relief
AstraZeneca’s Imfinzi Wins Japan Approval For Small Cell Lung Cancer
FDA Approves New Kyprolis Combination Regimen
A potential new weapon in the fight against COVID-19: Food coloring
Patient-to-Patient Supply for Cell Immunotherapies Summit
Why face masks can make eyes feel dry, and what you can do about it
CytoDyn Seeking UK Fast-Track Approval For Leronlimab In Covid-19
These 2 Beaten-Down Stocks Are Poised to Bounce Back, Say Analysts
AstraZeneca Gets FDA Priority Review For New Dose Of Imfinzi Cancer Drug
AZ aims to cut cancer clinic visits with new Imfinzi regimen
Krystal Biotech’s ‘Promising’ Cystic Fibrosis Drug Scores Orphan Designation
Gilead 'Very Pleased' With Tango Collab, Boosts Cancer Targets To 15
Poseida Sinks 35% On Prostate Cancer Trial Halt Following Patient Death
What Difference Does It Make?
Kiadis shares yo-yo on cell therapy trial for COVID-19
Billionaire Steven Cohen Pulls the Trigger on These 3 Penny Stocks
Ten Great Lessons From Billy Wilder Menschenkenner
CytoDyn Requests Covid-19 Emergency Use Approval For Leronlimab
OncoSec Prices $15M Offering; Analyst Sees Further 150% Upside Ahead
Masimo Gets FDA Clearance For Tracking Tool In Ventilated Adult Patients
Goldman Sachs: These 3 Stocks Can Deliver Big Returns for Investors
Baxter Gets FDA Emergency Use Nod For Regiocit During Covid-19 Pandemic